Vivian K Kawai1, Samuel K Nwosu2, Daniel Kurnik1,3,4, Frank E Harrell2, C Michael Stein1. 1. Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 2. Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 3. Clinical Pharmacology Unit, Rambam Health Care Campus, Haifa, Israel. 4. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Abstract
OBJECTIVE: The aim of this study is to define the association between a genetic risk score (GRS) that combined the effect of multiple BMI-associated variants and gestational weight trajectory. Because pregnancy is a state of sympathetic activation, the association between gestational weight trajectory and variants in adrenergic pathways previously associated with weight was examined. METHODS: In a previously defined cohort of pregnant women with (n = 1,504) and without gestational diabetes (GDM) (n = 435), weight trajectory was calculated using all weights during pregnancy. A GRS for BMI (GRSBMI ) was calculated using 31 common variants associated with BMI, and 10 variants in the adrenergic pathways were genotyped. Clinical and genetic factors were studied using generalized linear models. RESULTS: Prepregnancy BMI was associated with the GRSBMI (P = 9.3 × 10-11 ) and parity (P = 4.54 × 10-17 ). The GRSBMI was associated with gestational weight trajectory in women with and without GDM (P = 0.041 and P < 0.0001, respectively); however, when prepregnancy BMI was included in the models, the associations disappeared (P > 0.05). Variants in adrenergic genes were not associated with gestational weight trajectory. CONCLUSIONS: A GRS for BMI was associated with prepregnancy BMI but was not independently associated with gestational weight trajectory in women with and without GDM. Selected variants in adrenergic genes were not associated with gestational weight trajectory.
OBJECTIVE: The aim of this study is to define the association between a genetic risk score (GRS) that combined the effect of multiple BMI-associated variants and gestational weight trajectory. Because pregnancy is a state of sympathetic activation, the association between gestational weight trajectory and variants in adrenergic pathways previously associated with weight was examined. METHODS: In a previously defined cohort of pregnant women with (n = 1,504) and without gestational diabetes (GDM) (n = 435), weight trajectory was calculated using all weights during pregnancy. A GRS for BMI (GRSBMI ) was calculated using 31 common variants associated with BMI, and 10 variants in the adrenergic pathways were genotyped. Clinical and genetic factors were studied using generalized linear models. RESULTS: Prepregnancy BMI was associated with the GRSBMI (P = 9.3 × 10-11 ) and parity (P = 4.54 × 10-17 ). The GRSBMI was associated with gestational weight trajectory in women with and without GDM (P = 0.041 and P < 0.0001, respectively); however, when prepregnancy BMI was included in the models, the associations disappeared (P > 0.05). Variants in adrenergic genes were not associated with gestational weight trajectory. CONCLUSIONS: A GRS for BMI was associated with prepregnancy BMI but was not independently associated with gestational weight trajectory in women with and without GDM. Selected variants in adrenergic genes were not associated with gestational weight trajectory.
Authors: Aihua Li; Koon K Teo; Katherine M Morrison; Sarah D McDonald; Stephanie A Atkinson; Sonia S Anand; David Meyre Journal: Obesity (Silver Spring) Date: 2016-11-24 Impact factor: 5.002
Authors: V K Kawai; R T Levinson; A Adefurin; D Kurnik; S P Collier; D Conway; C M Stein Journal: Clin Endocrinol (Oxf) Date: 2017-05-26 Impact factor: 3.478
Authors: Sarah J Pugh; Paul S Albert; Sungduk Kim; William Grobman; Stefanie N Hinkle; Roger B Newman; Deborah A Wing; Katherine L Grantz Journal: Am J Obstet Gynecol Date: 2017-05-11 Impact factor: 8.661
Authors: K Yanagisawa; N Iwasaki; M Sanaka; S Minei; M Kanamori; Y Omori; Y Iwamoto Journal: Diabetes Res Clin Pract Date: 1999-04 Impact factor: 5.602
Authors: S Galjaard; A Pexsters; R Devlieger; I Guelinckx; Y Abdallah; C Lewis; B van Calster; T Bourne; D Timmerman; J Luts Journal: Obesity (Silver Spring) Date: 2013-05-29 Impact factor: 5.002
Authors: Shin Y Kim; Patricia M Dietz; Lucinda England; Brian Morrow; William M Callaghan Journal: Obesity (Silver Spring) Date: 2007-04 Impact factor: 5.002
Authors: Agnieszka H Ludwig-Słomczyńska; Michał T Seweryn; Przemysław Kapusta; Ewelina Pitera; Urszula Mantaj; Katarzyna Cyganek; Paweł Gutaj; Łucja Dobrucka; Ewa Wender-Ożegowska; Maciej T Małecki; Paweł P Wołkow Journal: Mol Med Date: 2021-01-20 Impact factor: 6.354